1Koneru M,Monu N,Schaer D,Barletta J,Frey AB.Defective adhesion in tumor infiltrating CD8+ T cells.J Immunol 2006;176:6103-6111.
2Waziri A,Killory B,Ogden AT 3rd,Canoll P,Anderson RC,Kent SC,Anderson DE,Bruce JN.Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma.J Immunol 2008; 180:7673-7680.
4Kasper HU,Drebber U,Zur Hausen A,Stippel D,Dienes HP,Dries V.Dominance of CD4+ alpha/beta T-cells and inferior role of innate immune reaction in liver metastases.Anticancer Res 2003; 23:3175-3181.
5Umansky V,Schirrmacher V,Rocha M.New insights into tumor-host interactions in lymphoma metastasis.J Mol Med 1996; 74:353-263.
6Disis ML,Bernhard H,Jaffee EM.Use of tumour-responsive T cells as cancer treatment.Lancet 2009; 373:673-683.
7Selmi C,Mackay IR,Gershwin ME.The immunological milieu of the liver.Semin Liver Dis 2007; 27:129-139.
8Roayaie S,Guarrera JV,Ye MQ,Thung SN,Emre S,Fishbein TM,Guy SR,Sheiner PA,Miller CM,Schwartz ME.Aggressive surgical treatment of intrahepatic cholangiocarcinoma:predictors of outcomes.J Am Coll Surg 1998; 187:365-372.
